DAX23.435 -1,1%ESt505.289 -1,0%Top 10 Crypto13,45 -5,3%Dow42.216 -0,7%Nas19.521 -0,9%Bitcoin91.230 -1,4%Euro1,1479 -0,7%Öl76,50 +5,5%Gold3.384 ±0,0%
Beliebte Suche
DAX 40 Ölpreis Euro - Dollar Bitcoin - Euro Goldpreis
Meistgesucht
Rheinmetall 703000 NVIDIA 918422 RENK RENK73 BYD A0M4W9 Siemens Energy ENER6Y Lufthansa 823212 Deutsche Telekom 555750 HENSOLDT HAG000 Tesla A1CX3T Commerzbank CBK100 Novo Nordisk A3EU6F Bayer BAY001 BASF BASF11 Infineon 623100 BioNTech (ADRs) A2PSR2
Alle Aktien für 0 Euro (zzgl. Spreads) handeln mit finanzen.net zero. Hier informieren
Heute im Fokus
Iran-Israel-Konflikt im Fokus: DAX schließt tief im Minus -- US-Börsen in Rot -- SoftBank verkauft Anteile von T-Mobile US im Milliardenwert -- Eli Lilly, Verve, D-Wave, Rheinmetall & Co. im Fokus
Top News
Palantir-Aktie nach Allzeithoch tiefer - Wie weit kann der Hype noch gehen? Palantir-Aktie nach Allzeithoch tiefer - Wie weit kann der Hype noch gehen?
D-Wave Quantum: Analyst hebt Kursziel kräftig an - Aktie nach Höhenflug leichter D-Wave Quantum: Analyst hebt Kursziel kräftig an - Aktie nach Höhenflug leichter
Suche...
Login
ODER

Neu auf finanzen.net?

Kostenfrei registrieren und Vorteile nutzen

Übersicht Wertpapierdepots Musterdepots Watchlists Meine News Newsletter Forum Trading Desk Apps Social Media Podcasts
Profil

Pfizer Aktie

Handeln
Pfizer Aktien-Sparplan
20,93 EUR -0,20 EUR -0,92 %
BMN
24,00 USD +0,01 USD +0,02 %
nachbörslich
BTT
Aktien, ETFs, Sparpläne & Kryptos zu Top-Konditionen beim Testsieger von finanztip.de handeln!
JETZT LOSLEGEN
Du hast schon ein ZERO-Konto? Direkt handeln bei ZERO!Bei einem anderen Broker handelnSmartphone

Marktkap.119,94 Mrd. EUR

KGV18,83Div. Rendite6,37%
WKN wurde kopiert
NEU
Handle jetzt direkt über finanzen.net mit Deinem Broker
Direkt handeln

WKN852009

ISIN wurde kopiert
NEU
Handle jetzt direkt über finanzen.net mit Deinem Broker
Direkt handeln

ISINUS7170811035

Symbol wurde kopiert
NEU
Handle jetzt direkt über finanzen.net mit Deinem Broker
Direkt handeln

SymbolPFE

Pfizer Aktien News

DatumMeistgelesen
BusinesswirePfizer Completes Acquisition of Global Blood Therapeutics 
BusinesswirePfizer Announces Positive Topline Results from Phase 3 TALAPRO-2 Trial
BusinesswirePfizer Completes Acquisition of Biohaven Pharmaceuticals
BusinesswirePfizer and BioNTech Submit Application to U.S. FDA for Emergency Use Authorization of Omicron BA.4/BA.5-Adapted Bivalent Vaccine Booster in Children 5 Through 11 Years of Age
MyDividendsPfizer zahlt 336. vierteljährliche Dividende in Folge
BusinesswirePfizer Declares Fourth-Quarter 2022 Dividend
BusinesswirePfizer to Supply Global Fund Up to 6 Million PAXLOVID™ Treatment Courses for Low-and-Middle-Income Countries
BusinesswirePfizer Invites Public to View and Listen to Webcast of November 1 Conference Call with Analysts
BusinesswirePfizer Announces Positive Top-Line Results from Phase 3 Study in 20-Valent Pneumococcal Conjugate Vaccine in Infants in the European Union
BusinesswirePfizer Announces Positive Top-Line Results from Phase 3 Trial of Pentavalent Meningococcal Vaccine Candidate (MenABCWY) in Adolescents
BusinesswirePfizer Invites Public to View and Listen to Webcast of Analyst and Investor Call to Review Oral GLP-1 Data Presented at European Association for the Study of Diabetes (EASD) 2022
BusinesswirePfizer Initiates Phase 3 Study of mRNA-Based Influenza Vaccine
PR NewswireStrata Oncology Announces Expansion of Clinical Collaboration with Pfizer for Strata PATH Trial into Early-Stage Cancer
BusinesswirePfizer and BioNTech Receive Positive CHMP Opinion for Omicron BA.4/BA.5-Adapted Bivalent COVID-19 Vaccine Booster in European Union
BusinesswireFDA and EMA Accept Regulatory Submission for Pfizer’s Ritlecitinib for Individuals 12 Years and Older with Alopecia Areata
BusinesswireFDA Grants Breakthrough Therapy Designation to Pfizer’s Group B Streptococcus Vaccine Candidate to Help Prevent Infection in Infants Via Immunization of Pregnant Women
BusinesswirePfizer Invites Public to View and Listen to Webcast of Pfizer Discussion at Healthcare Conference
BusinesswirePfizer Invites Public to View and Listen to a Webcast of Pfizer Discussion on Climate Action
MyDividendsPfizer schüttet 335. vierteljährliche Dividende in Folge aus
BusinesswirePfizer Invites Public to View and Listen to Two Webcasts of Pfizer Discussions at Healthcare Conferences
BusinesswirePfizer and BioNTech Receive Positive CHMP Opinion for Omicron BA.1-Adapted Bivalent COVID-19 Vaccine Booster in European Union
BusinesswirePfizer and BioNTech Granted FDA Emergency Use Authorization of Omicron BA.4/BA.5-Adapted Bivalent COVID-19 Vaccine Booster for Ages 12 Years and Older
PR NewswirePFIZER RANKED LEADING COMPANY IN ASIA FOR COVID-19 RESPONSE AND PATIENT-CENTRIC APPROACH BY ASIAN PATIENT GROUPS
BusinesswirePfizer Announces Positive Top-Line Data from Phase 3 Trial of Older Adults for its Bivalent Respiratory Syncytial Virus (RSV) Vaccine Candidate
BusinesswirePfizer and BioNTech Announce Updated COVID-19 Vaccine Data Supporting Efficacy in Children 6 Months through 4 Years of Age
BusinesswirePfizer and BioNTech Submit Application to U.S. FDA for Emergency Use Authorization of Omicron BA.4/BA.5-Adapted Bivalent COVID-19 Vaccine
BusinesswirePfizer Invites Public to View and Listen to Webcast of Pfizer Discussion at Healthcare Conference
BusinesswirePfizer Announces Positive Top-Line Results from Phase 3 Study of 20-Valent Pneumococcal Conjugate Vaccine in Infants
BusinesswirePfizer and Valneva Initiate Phase 3 Study of Lyme Disease Vaccine Candidate VLA15
PR NewswireSHAREHOLDER ALERT: Weiss Law Investigates Global Blood Therapeutics, Inc.
BusinesswirePfizer to Acquire Global Blood Therapeutics for $5.4 Billion to Enhance Presence in Rare Hematology
BusinesswirePFIZER REPORTS SECOND-QUARTER 2022 RESULTS
RSSGeneral statement of acquisition of beneficial ownership
BusinesswirePfizer Announces Submission of New Drug Application to the U.S. FDA for PAXLOVID™
BusinesswirePfizer and BioNTech Announce New Agreement with U.S. Government to Provide Additional Doses of COVID-19 Vaccine
RSSStatement of acquisition of beneficial ownership by individuals
BusinesswireRoivant and Pfizer Unveil Priovant Therapeutics and Ongoing Registrational Studies for Oral Brepocitinib in Dermatomyositis and Lupus
RSSStatement of acquisition of beneficial ownership by individuals
BusinesswirePfizer and BioNTech Announce Omicron-Adapted COVID-19 Vaccine Candidates Demonstrate High Immune Response Against Omicron
BusinesswirePfizer Invites Public to View and Listen to Webcast of July 28 Conference Call with Analysts

Pfizer News

Pfizer News: auf dieser Seite finden Sie alle Pfizer News und Nachrichten zur Pfizer Aktie. Dies beinhaltet die Agentur-Feeds auf finanzen.net, aber auch Pfizer News auf einer Vielzahl externer Seiten. Externe Links sind am entsprechenden Link-Symbol zu erkennen. Um Pfizer News auf externen Seiten zu lesen, folgen Sie einfach dem entsprechenden Link.